NTRA
Natera IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$29.88B
P/E Ratio
—
EPS
$-1.53
Beta
1.68
52W High
$256.36
52W Low
$131.81
50-Day MA
$207.90
200-Day MA
$192.86
Dividend Yield
—
Profit Margin
-9.03%
Forward P/E
—
PEG Ratio
0.00
About Natera Inc
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
Fundamentals
| Revenue (TTM) | $2.31B |
| Gross Profit (TTM) | $1.49B |
| EBITDA | $-271.43M |
| Operating Margin | -3.42% |
| Return on Equity | -14.30% |
| Return on Assets | -9.54% |
| Revenue/Share (TTM) | $16.87 |
| Book Value | $12.26 |
| Price-to-Book | 17.21 |
| Price-to-Sales (TTM) | 12.96 |
| EV/Revenue | 12.41 |
| EV/EBITDA | -26.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 39.80% |
| Shares Outstanding | $141.73M |
| Float | $137.44M |
| % Insiders | 3.04% |
| % Institutions | 94.46% |
Analyst Ratings
Consensus ($258.58 target)
5
Strong Buy12
Buy2
HoldData last updated: 4/9/2026